The Pfizer COVID-19 vaccine has not been fully approved by FDA
FDA letters to Pfizer Inc. and BioNTech Manufacturing GmbH On 23 August, FDA issued two letters – one addressed to Pfizer Inc. and the other to BioNTech Manufacturing GmbH. In the first letter, addressed to Pfizer Inc., FDA states that the EUA will remain in place for the Pfizer-BioNTech COVID-19 vaccine for the previously-authorised indication and uses, while authorising use of COMIRNATY (COVID-19 Vaccine, mRNA) under the same EUA for certain uses that are not included in theRead More→